ADMA Biologics Inc (NASDAQ:ADMA)
| 1.38 Delayed Data As of Nov 30 |  -0.07 / -4.83%Today’s Change | 1.01 Today|||52-Week Range 3.11 | -29.23% Year-to-Date |
Latest ADMA News | Press Releases
No recent news for ADMA Biologics Inc.
Today’s Trading
| Previous close | 1.45 |
| Today’s open | 1.43 |
| Day’s range | 1.37 - 1.45 |
| Volume | 1,387,825 |
| Average volume (3 months) | 3,080,178 |
| Market cap | $283.9M |
Data as of 4:00pm ET, 11/30/2021
Growth & Valuation
| Earnings growth (last year) | +1.01% |
| Earnings growth (this year) | +39.77% |
| Earnings growth (next 5 years) | +14.00% |
| Revenue growth (last year) | +43.85% |
| P/E ratio | NM |
| Price/Sales | 3.98 |
| Price/Book | 1.72 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| URGNUrogen Pharma Ltd | +0.17 | +1.43% |
| SURFSurface Oncology Inc | +0.04 | +0.70% |
| NMTR9 Meters Biopharma I... | +0.01 | +0.97% |
| CODXCo-Diagnostics Inc | +0.34 | +3.66% |
Data as of 4:00pm ET, 11/30/2021
Financials
| Next reporting date | March 24, 2022 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $42.2M |
| Annual profit (last year) | -$75.7M |
| Net profit margin | -179.41% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Ramsey, New Jersey |
Forecasts
